Cargando…

Revisiting respiratory syncytial virus’s interaction with host immunity, towards novel therapeutics

Every year there are > 33 million cases of Respiratory Syncytial Virus (RSV)-related respiratory infection in children under the age of five, making RSV the leading cause of lower respiratory tract infection (LRTI) in infants. RSV is a global infection, but 99% of related mortality is in low/midd...

Descripción completa

Detalles Bibliográficos
Autores principales:	Efstathiou, C., Abidi, S. H., Harker, J., Stevenson, N. J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer International Publishing 2020
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7298439/ https://www.ncbi.nlm.nih.gov/pubmed/32556372 http://dx.doi.org/10.1007/s00018-020-03557-0

Ejemplares similares

Birth cohort relative to an influenza A virus’s antigenic cluster introduction drives patterns of children’s antibody titers
por: Brouwer, Andrew F., et al.
Publicado: (2022)

Delayed Sequelae of Neonatal Respiratory Syncytial Virus Infection Are Dependent on Cells of the Innate Immune System
por: Harker, James A., et al.
Publicado: (2014)

Host Responses to Respiratory Syncytial Virus Infection
por: Agac, Ayse, et al.
Publicado: (2023)

Receptors for Respiratory Syncytial Virus Infection and Host Factors Regulating the Life Cycle of Respiratory Syncytial Virus
por: Feng, Ziheng, et al.
Publicado: (2022)

Host Components Contributing to Respiratory Syncytial Virus Pathogenesis
por: Carvajal, Jonatan J., et al.
Publicado: (2019)

Mucosal Immune Responses to Respiratory Syncytial Virus
por: Barnes, Megan V. C., et al.
Publicado: (2022)

Host cytoskeleton in respiratory syncytial virus assembly and budding
por: Shahriari, Shadi, et al.
Publicado: (2016)

Host and Viral Factors in Respiratory Syncytial Virus Infection
por: Mastrangelo, Peter, et al.
Publicado: (2013)

A novel host factor for human respiratory syncytial virus
por: Mehedi, Masfique, et al.
Publicado: (2017)

Challenges and Opportunities in Developing Respiratory Syncytial Virus Therapeutics
por: Simões, Eric A. F., et al.
Publicado: (2015)

Respiratory syncytial virus: The virus, the disease and the immune response
por: Ogra, Pearay L.
Publicado: (2004)

Discovery of Hybrid Thiouracil–Coumarin Conjugates as Potential Novel Anti-SARS-CoV-2 Agents Targeting the Virus’s Polymerase “RdRp” as a Confirmed Interacting Biomolecule
por: Vishwanath, Divakar, et al.
Publicado: (2023)

Virogenomics: the virus–host interaction revisited
por: Andeweg, Arno C, et al.
Publicado: (2008)

The continuing need for therapeutic agents for respiratory syncytial virus infection
por: Roberts, Norbert J
Publicado: (2023)

Respiratory Syncytial Virus (RSV) Modulation at the Virus-Host Interface Affects Immune Outcome and Disease Pathogenesis
por: Tripp, Ralph A.
Publicado: (2013)

Cotton rat lung transcriptome reveals host immune response to Respiratory Syncytial Virus infection
por: Rajagopala, Seesandra V., et al.
Publicado: (2018)

Respiratory Syncytial Virus
por: Fraire, Armando E., et al.
Publicado: (2013)

Respiratory syncytial virus
por: Ruuskanen, Olli, et al.
Publicado: (1993)

Respiratory syncytial virus
por: Munoz, Flor M., et al.
Publicado: (2020)

Innate immune recognition of respiratory syncytial virus infection
por: Kim, Tae Hoon, et al.
Publicado: (2014)

Respiratory syncytial virus: paying the immunity debt with interest
por: Hatter, Lee, et al.
Publicado: (2021)

Innate Immune Evasion by Human Respiratory Syncytial Virus
por: Ouyang, Yan, et al.
Publicado: (2022)

A Not-So-Good Way to Die? Respiratory Syncytial Virus–induced Necroptotic Cell Death Promotes Inflammation and Type 2–mediated Pathology
por: Harker, James A., et al.
Publicado: (2020)

Interactions of heparin with key glycoproteins of human respiratory syncytial virus
por: Shi, Deling, et al.
Publicado: (2023)

Therapeutic efficacy of a respiratory syncytial virus fusion inhibitor
por: Roymans, Dirk, et al.
Publicado: (2017)

Respiratory syncytial virus: from pathogenesis to potential therapeutic strategies
por: Shang, Zifang, et al.
Publicado: (2021)

Respiratory syncytial virus, an ongoing medical dilemma: an expert commentary on respiratory syncytial virus prophylactic and therapeutic pharmaceuticals currently in clinical trials
por: Broadbent, Lindsay, et al.
Publicado: (2015)

Towards a unified classification for human respiratory syncytial virus genotypes
por: Ramaekers, Kaat, et al.
Publicado: (2020)

Respiratory Syncytial Virus (RSV) Update
por: Krilov, Leonard R., et al.
Publicado: (2022)

An Overview of Respiratory Syncytial Virus
por: Meng, Jia, et al.
Publicado: (2014)

Respiratory Syncytial Virus (RSV)
por: Walsh, Edward E., et al.
Publicado: (2015)

RIBAVIRIN AND RESPIRATORY SYNCYTIAL VIRUS
Publicado: (1986)

Bovine Respiratory Syncytial Virus
por: WELLEMANS, G.
Publicado: (1990)

An update on respiratory syncytial virus
por: Piralla, Antonio, et al.
Publicado: (2023)

Respiratory syncytial virus co-opts host mitochondrial function to favour infectious virus production
por: Hu, MengJie, et al.
Publicado: (2019)

Protection against Respiratory Syncytial Virus Infection by DNA Immunization
por: Li, Xiaomao, et al.
Publicado: (1998)

Mechanisms of Respiratory Syncytial Virus Modulation of Airway Immune Responses
por: Lotz, Matthew T., et al.
Publicado: (2012)

Microbiome-Transcriptome Interactions Related to Severity of Respiratory Syncytial Virus Infection
por: Sonawane, Abhijeet R., et al.
Publicado: (2019)

Novel insights into human respiratory syncytial virus-host factor interactions through integrated proteomics and transcriptomics analysis
por: Dapat, Clyde, et al.
Publicado: (2016)

873. Using the Host Immune Response to Identify Viral-Bacterial Coinfection in Children With Respiratory Syncytial Virus Infection
por: Mastboim, Niv, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_gsohvr78vi5853hhdd54mc3sc7